Professor Steve Ley CBE FRS FMedSci

Director of Research

In the Ley Group, we specialise in developing new synthesis methods and applying them to the construction of biologically important molecules. Over the last 10 years we have completed the total synthesis of 28 natural products including spongistatin 1 (anti-mitotic agent), rapamycin (immunosuppressant), thapsigargin (SERCA pumps inhibitor), azadirachtin (insect antifeedant) and bengazole A (fungicide), taking our group total to 150 completed total syntheses. In addition to our research on natural product synthesis, we also have a new state-of-the-art flow chemistry facility.

For more detailed research information, group members and our publication list please see the group website.

Publications

Back pressure regulation of slurry-forming reactions in continuous flow

BJ Deadman, DL Browne, IR Baxendale, SV Ley

– Chemical Engineering and Technology

(2015)

38,

259

(doi: 10.1002/ceat.201400445)

Chemistry in a changing world

SV Ley, RM Myers, DE Fitzpatrick

– Actualite Chimique

(2015)

Flow chemistry: intelligent processing of gas-liquid transformations using a tube-in-tube reactor.

M Brzozowski, M O'Brien, SV Ley, A Polyzos

– Accounts of Chemical Research

(2015)

48,

349

(doi: 10.1021/ar500359m)

Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2.

MS Christodoulou, F Calogero, M Baumann, AN García-Argáez, S Pieraccini, M Sironi, F Dapiaggi, R Bucci, G Broggini, S Gazzola, S Liekens, A Silvani, M Lahtela-Kakkonen, N Martinet, A Nonell-Canals, E Santamaría-Navarro, IR Baxendale, L Dalla Via, D Passarella

– European Journal of Medicinal Chemistry

(2015)

92,

766

(doi: 10.1016/j.ejmech.2015.01.038)